La cadena de opciones muestra datos clave de las opciones de acciones de Reliance Global Group a varios precios de ejercicio y fechas de vencimiento. Los operadores utilizan esta información para analizar posibles operaciones y evaluar el sentimiento del mercado para Reliance Global Group..

Reliance Global Group (NASDAQ:RELI) Bolsa, Cadena de Opciones

Reliance Global Group

Reliance Global Group Inc operates as a holding company with diversified interests in the insurance market, as well as other related sectors. The company focuses on growing by pursuing acquisition strategies, initially and focused on wholesale and retail insurance agencies. Its primary strategies is to identify specific risks to reward arbitrage opportunities and develop these on a national platform, thereby increasing revenues and returns, and then identify and acquire undervalued wholesale and retail insurance agencies with operations in growing or underserved segments, expand and optimize their operations, and achieve asset value appreciation while generating interim cash flows. The company generates revenue in the form of commissions.

News

Pre-Market Outlook

Markets

Movers

Trading Ideas

AMPG

AVGR

BIPC

CHEK

CREV

FDSB

HSDT

KORE

LAES

LIND

NCRA

NEUE

NVNI

RELI

SLGL

TIVC

TLRY

TOVX

Carbon Revolution lidera con un aumento del 62,4% en el premercado. ¿Qué otras acciones destacaron antes de la apertura?

Las acciones de Carbon Revolution (CREV) están subiendo un 62%; 20 acciones que se están moviendo en el premercado

Reliance Global Group, Inc. - Common Stock

Reliance Global Group Inc

Reliance Global Group, Inc. - Series A Warrants

RELIANCE INFRAST GDR 144A by Reliance Infrastructure Ltd.

Reliability Inc

Reliance Inc

RELIANCE INDUS GDR 144A by Reliance Industries Ltd.

Reliance Industries Ltd

Reliance Infrastructure Ltd GDR

RELIANCE WORLDWIDE ORD by Reliance Worldwide Corp Ltd.

Reliance Worldwide Corp Ltd

RELIANT FINCL SVC CORP by Reliant Financial Service Corp.

Reliant Financial Service Corp

Reliant Holdings Inc

Relief Therapeutics Holding SA

RELIEF THERAPEUTICS HLDG by RELIEF THERAPEUTICS HLDG AG

RELIEF THERAPEUTICS S/ADR by RELIEF THERAPEUTICS HLDG AG

Relief Therapeutics Holding SA ADR

RELIQ HEALTH TECHS INC by Reliq Health Technologies Inc.

Reliq Health Technologies Inc

RELIV INTL INC by Reliv International, Inc.

Reliv' International Inc

Snap Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SNAP#NYSE">SNAP</a>) is in the spotlight ahead earnings Tuesday. Here&#8217;s what you <a href="https://www.benzinga.com//node/45046664">need to know.</a>
What To Know: Analysts&#8217; estimate first-quarter earnings of 3 cents per share and revenue of $1.35 billion, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro.</a>
The company previously guided for revenue between $1.23 billion and $1.36 billion and adjusted EBITDA between $40 million and $75 million for the first-quarter.
Snap also expects infrastructure costs per daily active user to be between 82 cents and 87 cents. Content, developer, advertising partner and other costs are expected to represent 19% to 20% of revenue.
In its last letter to shareholders, the company said, &#8220;As we look ahead to 2025, we see additional opportunities to invest productively in scaling our business given the foundational improvements we have made to our ad platform and the momentum we have established in our go to market initiatives, particularly the SMB segment. Our investment plans for 2025 reflect this optimism, alongside a strong commitment to make further financial progress towards profitability as we scale.&#8221;
See Also: <a href="https://www.benzinga.com/trading-ideas/movers/25/04/45067585/amazon-stock-tumbles-as-white-house-calls-tariff-visibility-plans-a-hostile-act">Amazon Stock Tumbles As White House Calls Tariff Visibility Plans A &#8216;Hostile&#8217; Act</a>
SNAP Price Action: At the time of writing, Snap stock is trading 1.0.8% higher at $8.92, per data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro.</a>
Image: via Shutterstock

SNAP

What's Going On With Snap Stock Tuesday?

UBS analyst Timothy Arcuri maintains Skyworks Solutions (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SWKS#NASDAQ">SWKS</a>) with a Neutral and lowers the price target from $70 to $65.

Price Target

Analyst Ratings

SWKS

UBS Maintains Neutral on Skyworks Solutions, Lowers Price Target to $65

UBS analyst John Nadel maintains Principal Financial Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PFG#NASDAQ">PFG</a>) with a Neutral and lowers the price target from $93 to $80.

UBS Maintains Neutral on Principal Financial Group, Lowers Price Target to $80

UBS analyst Pradeep Ramani maintains ON Semiconductor (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ON#NASDAQ">ON</a>) with a Neutral and lowers the price target from $55 to $40.

UBS Maintains Neutral on ON Semiconductor, Lowers Price Target to $40

WIIM

Wells Fargo shares are trading higher after the company's board authorized a $40 billion stock repurchase program.

UBS analyst Kunal Madhukar maintains Match Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MTCH#NASDAQ">MTCH</a>) with a Neutral and lowers the price target from $34 to $31.

MTCH

UBS Maintains Neutral on Match Group, Lowers Price Target to $31

Correction: Guggenheim analyst Michael Schmidt downgrades SpringWorks Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SWTX#NASDAQ">SWTX</a>) from Buy to Neutral and lowers the price target from $77 to $47. (Analyst Firm change from Stephens &amp; Co. to Guggenheim)

Downgrades

SWTX

Correction: Guggenheim Downgrades SpringWorks Therapeutics to Neutral, Lowers Price Target to $47 (Firm change from Stephens & Co. to Guggenheim)

BMO Capital analyst Michael Zaremski maintains Selective Insurance Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SIGI#NASDAQ">SIGI</a>) with a Outperform and raises the price target from $92 to $96.

SIGI

BMO Capital Maintains Outperform on Selective Insurance Gr, Raises Price Target to $96

UBS analyst Taylor McGinnis maintains Monday.Com (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MNDY#NASDAQ">MNDY</a>) with a Neutral and lowers the price target from $350 to $310.

MNDY

UBS Maintains Neutral on Monday.Com, Lowers Price Target to $310

BMO Capital analyst Ari Klein maintains SBA Communications (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SBAC#NASDAQ">SBAC</a>) with a Market Perform and raises the price target from $230 to $240.

SBAC

BMO Capital Maintains Market Perform on SBA Communications, Raises Price Target to $240

UBS analyst Pradeep Ramani maintains Microchip Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MCHP#NASDAQ">MCHP</a>) with a Buy and lowers the price target from $70 to $55.

MCHP

UBS Maintains Buy on Microchip Technology, Lowers Price Target to $55

AZZ (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AZZ#NYSE">AZZ</a>) has outperformed the market over the past 20 years by 8.88% on an annualized basis producing an average annual return of 16.92%. Currently, AZZ has a market capitalization of $2.57 billion. 
Buying $1000 In AZZ: If an investor had bought $1000 of AZZ stock 20 years ago, it would be worth $22,594.59 today based on a price of $86.00 for AZZ at the time of writing.
<h3>AZZ's Performance Over Last 20 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1745937911_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

If You Invested $1000 In This Stock 20 Years Ago, You Would Have This Much Today

BMO Capital analyst Andrew Strelzik maintains Domino's Pizza (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DPZ#NASDAQ">DPZ</a>) with a Outperform and raises the price target from $515 to $540.

BMO Capital Maintains Outperform on Domino's Pizza, Raises Price Target to $540

UBS analyst Danielle Antalffy maintains InMode (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INMD#NASDAQ">INMD</a>) with a Neutral and lowers the price target from $19 to $16.25.

INMD

UBS Maintains Neutral on InMode, Lowers Price Target to $16.25

BMO Capital analyst James Thalacker maintains CMS Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CMS#NYSE">CMS</a>) with a Outperform and raises the price target from $77 to $79.

BMO Capital Maintains Outperform on CMS Energy, Raises Price Target to $79

UBS analyst Timothy Arcuri maintains GLOBALFOUNDRIES (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GFS#NASDAQ">GFS</a>) with a Neutral and lowers the price target from $45 to $37.

UBS Maintains Neutral on GLOBALFOUNDRIES, Lowers Price Target to $37

Piper Sandler analyst James Fish maintains F5 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FFIV#NASDAQ">FFIV</a>) with a Neutral and raises the price target from $262 to $269.

FFIV

Piper Sandler Maintains Neutral on F5, Raises Price Target to $269

UBS analyst Timothy Arcuri maintains Entegris (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ENTG#NASDAQ">ENTG</a>) with a Neutral and lowers the price target from $115 to $90.

ENTG

UBS Maintains Neutral on Entegris, Lowers Price Target to $90

Piper Sandler analyst Matt O'Brien reiterates TransMedics Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TMDX#NASDAQ">TMDX</a>) with a Overweight and raises the price target from $90 to $105.

Reiteration

TMDX

Piper Sandler Reiterates Overweight on TransMedics Group, Raises Price Target to $105

UBS analyst Timothy Arcuri maintains ARM Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARM#NASDAQ">ARM</a>) with a Buy and lowers the price target from $215 to $165.

UBS Maintains Buy on ARM Holdings, Lowers Price Target to $165

Press Releases

Reliance Global Group Announces Enhanced Terms for Pending Spetner Acquisition

Reliance Global Group Launches Beta Version of Advanced Quote & Bind InsurTech Solution for Commercial Policies, Ahead of Schedule

Reliance Global Group Schedules Third Quarter 2024 Financial Results and Business Update Conference Call

Earnings

Reliance Global Group Reports Third Quarter 2024 Results and Provides Business Update

Reliance Global Now Adjusted EBITDA Positive With Growing Revenue Reflecting Potential Benefits Of OneFirm Approach

Reliance Global Group Reflects on a Transformative Year and Looks Ahead to 2025

Reliance Global Group Expands RELI Exchange Commercial Quote & Bind InsurTech Platform Following Successful Beta Launch

Reliance Global Group Schedules Fourth Quarter and Year Ended December 31, 2024 Financial Results and Business Update Conference Call

Reliance Global Group Reports 2024 Results and Provides Business Update

Reliance Global Group Launches RELI Auto Leasing—Delivering ANY Vehicle to ANY Location in the United States

RELIW

AIFU

Cheche Group Inc. - Class A Ordinary Shares

Cheche Group

Crawford & Company Common Stock

eHealth

GoHealth

Health In Tech, Inc. - Class A Common Stock

Health In Tech

Huize Holding Limited - American Depositary Shares

Huize Holding

TIAN RUIXIANG Holdings Ltd - Class A Ordinary Shares

Tian Ruixiang Holdings

TWFG

Waterdrop Inc. American Depositary Shares (each representing the right to receive 10 Class A Ordinary Shares)

Waterdrop

XChange TEC.INC - American Depositary Shares

XChange Tec

Zhibao Technology Inc. - Class A Ordinary Shares

Comments

Reliance Global Group

Reliance Global Group (RELI) Opciones

No option chain data available. Please try again later

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL